(April 28th, 2022; Finch Therapeutics Group Inc)
The announcement that the FDA has removed the clinical hold on Finch’s investigational new drug (IND) application for CP101, following a review of information Finch provided related to its SARS-CoV-2 screening procedures and associated informed consent language, sent the FNCH stock price soaring during premarket hours today. Date: April 28th, 2022 Full company name: Finch Therapeutics Group Inc
Commentaires